Twist Bioscience Corp. (TWST) is a synthetic biology company that produces synthetic genes, oligonucleotide pools, and variant libraries. The company's platform technology, called DNA synthesis, allows for the high-throughput production of synthetic genes and DNA sequences for use in a variety of applications, including gene editing, drug discovery, and biomanufacturing. Twist Bioscience also offers custom gene synthesis services and software tools for gene design and optimization. The company is headquartered in South San Francisco, California, and as of September 2021, had a market capitalization of approximately $5.5 billion.
Twist Bioscience Corp. (TWST) is a synthetic biology company that produces synthetic genes, oligonucleotide pools, and variant libraries. The company's platform technology, called DNA synthesis, allows for the high-throughput production of synthetic genes and DNA sequences for use in a variety of applications, including gene editing, drug discovery, and biomanufacturing. Twist Bioscience also offers custom gene synthesis services and software tools for gene design and optimization. The company is headquartered in South San Francisco, California, and as of September 2021, had a market capitalization of approximately $5.5 billion.